Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Figures | 2022 | Seed | $6.8M | Paris |
| Sympatient | 2022 | Series A | $7.4M | Hamburg |
| Locatee | 2021 | Series B | $8.3M | Zürich |
| Insolight | 2025 | Debt Financing | $1.2M | Lausanne |
| EarlySight | 2025 | Seed | $3.9M | Lausanne |
| Puraffinity | 2024 | Series A | $8.8M | London |
| marta | 2023 | Seed | Undisclosed | Berlin |
| IRUBIS | 2024 | Seed | Undisclosed | München |
| Threatray | 2024 | Venture - Series Unknown | Undisclosed | Biel |
| Humanoo | 2021 | Series B | $10.0M | Berlin |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Figures | Seed | $6.8M | Paris, France |
| 2 | Sympatient | Series A | $7.4M | Hamburg, Germany |
| 3 | Locatee | Series B | $8.3M | Zürich, Switzerland |
| 4 | Insolight | Debt Financing | $1.2M | Lausanne, Switzerland |
| 5 | EarlySight | Seed | $3.9M | Lausanne, Switzerland |
| 6 | Puraffinity | Series A | $8.8M | London, United Kingdom |
| 7 | marta | Seed | Undisclosed | Berlin, Germany |
| 8 | IRUBIS | Seed | Undisclosed | München, Germany |
| 9 | Threatray | Venture - Series Unknown | Undisclosed | Biel, Switzerland |
| 10 | Humanoo | Series B | $10.0M | Berlin, Germany |
Figures provides real time compensation intelligence to companies, with the most extensive benchmark for European venture-backed companies.
An operating system for modern psychotherapy - combining care structures and technology within regulated healthcare for better results.
Locatee is a workplace analytics solution that transforms data into space utilization insights.
Insolight is an energy company that develops and manufactures solar panels.
EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water
marta provides software for the live-in care market that empowers caregivers and helps our seniors to age in dignity.
IRUBIS offers bioprocessing and infrared spectroscopy services.
Threatray produces code-based threat intelligence by making massive malware repositories and feeds searchable and correlatable.
Europe's biggest automated corporate wellness solution for productive teams & healthy people
Scrona is a manufacturing company that focuses on developing a wide range of semiconductor products.
Comphya developing an active implantable medical device to restore the erectile function of patient non-responsive to oral drugs.
Advanced wound care, made personal.
A Paris-based biotechnology company .
Nezasa’s travel booking solution empowers travel brands globally to combine planning and booking into one seamless end-to-end experience.
Turn2x is developing its cutting-edge technology for producing renewable natural gas (RNG).
Biograil is a biotech company manufacturing an oral device for delivery of biologics
Oper is a reliable technology partner that enables lenders to leverage their mortgage offerings.
CREAL develops near-eye light-field display bringing true optical depth and better immersion into virtual and mixed reality.
ORCA Computing is building the first scalable and flexible quantum computer powered by photonics.
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.
Atana is a data-driven resource company that accelerates the exploration and development of flowing critical minerals.
Wildbiene + Partner contributes to a balanced ecosystem by providing sustainable pollination and high-quality bee experiences.
Goodwall is a social development platform for young people to connect over shared interests and discover opportunities.
Abionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology.
Verve Ventures has invested in 200 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Verve Ventures's top investment sectors include Health Care, Software, Biotechnology, Information Technology, Manufacturing. The firm invests across 66 different industry categories.
Among tracked funding rounds, ORCA Computing received $15.0M in a Series A round. Verve Ventures's total known invested capital is $2.5B.
Verve Ventures's average investment size is $14.9M across its portfolio of 200 companies.
Recent Verve Ventures portfolio additions include Figures, Sympatient, Locatee, Insolight, EarlySight. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors